Healthcare News

BERKELEY, Calif., Sept. 29, 2006 (PRIMEZONE) -- XOMA Ltd. (Nasdaq:XOMA) today announced its plans for its chief financial officer, Mr. David Boyle, to present an overview of its business strategy and...

BOHEMIA, N.Y., Sept. 29, 2006 (PRIMEZONE) -- Scientific Industries Inc. (OTCBB:SCND), September 29, 2006 - Scientific Industries Inc., today reported that for the year ended June 30, 2006 net income...

BEIJING, Sept. 29, 2006 (PRIMEZONE) -- Lotus Pharmaceuticals International, Inc. announced that it has attained public company status on the Over-the-Counter Bulletin Board, by having successfully...

Oslo, Norway, 29 September 2006   This phase IIA study is a dose selection study comparing 3 different doses of MAL cream and 4 different durations prior to light exposure in 43 patients with...

Oslo, 29. september 2006   Denne fase IIA studien er en dose-valg studie hvor 3 forskjellige krem konsentrasjoner og 4 forskjellige perioder fra påføring av krem til belysning ble sammenlignet...

BASEL, Switzerland, Sept. 29, 2006 (PRIMEZONE) -- Ceftobiprole is the first anti-MRSA broad-spectrum cephalosporin to demonstrate efficacy in a large clinical trial in patients infected with...

BASEL, Switzerland, Sept. 29, 2006 (PRIMEZONE) -- Data presented at ICAAC further support phase III development program scheduled to start by year-end in invasive candida (yeast) and aspergillus...

Malaria strikes 300 million to 500 million people every year, the biggest killer of children in Africa - every 30 seconds a child in Africa dies of this disease Average cost per Coartem...

Basel, Switzerland, September 29, 2006 - Data presented at ICAAC further support phase III development program scheduled to start by year-end in invasive candida (yeast) and aspergillus (mold)...

Basel, 29. September, 2006 - Die an der ICAAC präsentierten Ergebnisse bestätigen das Potential des Pilzmittels zur Behandlung von invasiven Candida- (Hefepilz) und Aspergillus- (Schimmelpilz)...